IMARC Group, a leading market research company, has recently released a report titled “Needle-free Drug Delivery Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”. The study provides a detailed analysis of the industry, including the needle-free drug delivery technology market size, share, trends and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the Needle-free Drug Delivery Technology Market?
The global needle-free drug delivery technology market size reached US$ 4.18 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.72 Billion by 2028, exhibiting a growth rate (CAGR) of 5.22% during 2023-2028.
What is a Needle-free Drug Delivery Technology?
Needle-free drug delivery technology offers a non-invasive method of administering medications without traditional needles. It encompasses various approaches such as micronozzle jet injectors, transdermal patches, inhalers, nasal sprays, and ultrasound waves. This technology is widely utilized for vaccinations, insulin delivery, pain management, hormone therapy, and treating chronic diseases like allergies, cancer, and respiratory conditions. Compared to needle-based systems, it reduces pain, discomfort, anxiety, and the risk of injuries and infections. Additionally, it enhances convenience, patient compliance, dosage customization, and medication absorption while being eco-friendly by minimizing hazardous waste generation and manufacturing emissions.
Request for a sample copy of this report: https://www.imarcgroup.com/needle-free-drug-delivery-technology-market/requestsample
What are the growth prospects and trends in the needle-free drug delivery technology industry?
The growing prevalence of chronic diseases like diabetes, cancer, cardiovascular diseases (CVDs), and arthritis drives the adoption of needle-free drug delivery technology. This method is particularly beneficial for delivering insulin and medications to chronic disease patients, improving treatment outcomes, and enhancing their quality of life. The technology's advantages in improving medication adherence, drug absorption, and minimizing complications also contribute to its popularity. Innovations like laser-powered needle-free injection technology (NFIT) further boost market growth by providing precise drug delivery. The technology finds applications in veterinary care, promoting stress-free administration of vaccines, medications, and anesthesia to animals. Government initiatives supporting technology adoption and advanced development, coupled with increasing demand for vaccines and healthcare growth, fuel the market's positive outlook. Extensive research and consumer awareness about the technology's benefits are additional drivers for market growth.
What is included in market segmentation?
The report has segmented the market into the following categories:
Product Insights:
- Inhaler
- Jet Injector
- Novel Needles
- Transdermal Patch
- Others
Application Insights:
- Vaccine Delivery
- Pain Management
- Insulin Delivery
- Others
End User Insights:
- Hospitals and Clinics
- Homecare Settings
- Research Laboratories
- Academics
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Akra Dermojet,
- Antares Pharma Inc. (Halozyme Therapeutics Inc.),
- Crossject,
- Mika Medical Co.,
- PharmaJet,
- Portal Instruments Inc.
Ask Analyst for Sample Report: https://www.imarcgroup.com/request?type=report&id=7818&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal